These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6540761)

  • 21. Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines.
    Mineura K; Kowada M
    Cell Biol Int; 1996 May; 20(5):355-7. PubMed ID: 8688852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
    Yim EK; Lee SB; Lee KH; Kim CJ; Park JS
    Int J Gynecol Cancer; 2006; 16(3):1321-9. PubMed ID: 16803524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
    Takara K; Fujita M; Minegaki T; Yamamoto K; Takahashi M; Yokoyama T; Okumura K
    Eur J Pharm Sci; 2012 Feb; 45(3):272-81. PubMed ID: 22155546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
    Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of spirogermanium given by infusion in a multiple-dose schedule.
    Budman DR; Schulman P; Vinciguerra V; Degnan TJ
    Cancer Treat Rep; 1982 Jan; 66(1):173-5. PubMed ID: 7053254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
    Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
    Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
    Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
    [No Abstract]   [Full Text] [Related]  

  • 31. Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.
    Hug V; Hortobagyi GN; Drewinko B; Finders M
    J Clin Oncol; 1985 Dec; 3(12):1672-7. PubMed ID: 4067614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
    McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
    J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
    Brenner DE; Jones HW; Rosenshein NB; Forastiere A; Dillon M; Grumbine F; Tipping S; Burnett L; Greco FA; Wiernik PH
    Cancer Treat Rep; 1983 Feb; 67(2):193-4. PubMed ID: 6825131
    [No Abstract]   [Full Text] [Related]  

  • 34. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
    Kavanagh JJ; Saul PB; Copeland LJ; Gershenson DM; Krakoff IH
    Cancer Treat Rep; 1985 Jan; 69(1):139-40. PubMed ID: 3967257
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.
    Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M
    Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
    Welander CE; Morgan TM; Homesley HD; Trotta PP; Spiegel RJ
    Int J Cancer; 1985 Jun; 35(6):721-9. PubMed ID: 4008100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Treat Rep; 1985 Mar; 69(3):279-83. PubMed ID: 4038918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.